Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Viridian Therapeutics, Inc. | VRDN | 93.41K | $1.72M |
Kymera Therapeutics, Inc. | KYMR | 772.16K | $88.54M |
Aktis Oncology, Inc. | AKTS | 952.84K | $30.71M |
Entrada Therapeutics, Inc. | TRDA | 1.74M | $12.8M |
Moderna, Inc. | MRNA | 2.31M | $161.64M |